General description
The pCDF-1b plasmid features coexpression capabilities as well as the ability to express fusion proteins with a N-terminal His•Tag that results in native protein after purification and cleavage. This plasmid carries an origin derived from CloDF13 (1) and streptomycin/spectinomycin resistance, allowing for the option of coexpression with many other Novagen T7-based expression vectors.
The vector contains a T7 promoter, lac operator, ribosome binding site (rbs), an amino terminal His•Tag
This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges us to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form.
Warning
Toxicity: Standard Handling (A)
Other Notes
1. Nijkamp, H.J.J., De Lang, R., Stuitje, A.R., Van Den Elzen P.J.M., Veltkamp, E., and Van Putten, A.J. (1986) Plasmid16, 135–160.
2. Kim, J.S. and Raines, R.T. (1993) Protein Science2, 348–356.
Legal Information
NOVAGEN is a registered trademark of Merck KGaA, Darmstadt, Germany
form: liquid. Quality Level: 100. manufacturer/tradename: Novagen®. . storage condition: OK to freeze. storage temp.: −. 70°C. Storage Class Code: 12 - Non Combustible Liquids. WGK: WGK 1. Flash Point(F): Not applicable. Flash Point(C): Not applicable.- UPC:
- 41106300
- Condition:
- New
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- 71330-3